SARTORIUS AG
ISIN: DE0007165631
WKN: 716563
16 February 2026 10:36AM

EQS-News: Sartorius sharpens climate targets and receives validation from Science Based Targets initiative

SARTORIUS AG · ISIN: DE0007165631 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2276308

EQS-News: SARTORIUS AG / Key word(s): Sustainability/ESG
Sartorius sharpens climate targets and receives validation from Science Based Targets initiative (news with additional features)

16.02.2026 / 10:36 CET/CEST
The issuer is solely responsible for the content of this announcement.


Göttingen, Germany | February 16, 2026

Sartorius sharpens climate targets and receives validation from Science Based Targets initiative
 
  • Ambitious new medium-term targets set for Scopes 1, 2, and 3
  • SBTi confirms compatibility of science-based reduction targets with Paris Climate Agreement
  • Long-term ambition remains unchanged: net-zero greenhouse gas emissions by 2045

The life science group Sartorius has sharpened its medium-term climate targets and received validation from the Science Based Targets initiative (SBTi). The organization confirmed that the new greenhouse gas reduction targets are in line with the Paris Climate Agreement.

“We have refined our climate targets and, with SBTi validation, taken an important step that is increasingly expected in our industry: science-based targets aligned with the United Nations’ decarbonization pathways. This underscores our level of ambition,” said Sartorius CEO Dr. Michael Grosse. “At the same time, we are turning ambition into action: We are transitioning our sites to renewable energy, working closely with customers and suppliers to advance the use of low-emission materials and processes, and applying eco-design principles to a growing share of our product portfolio. This is how we reduce our own footprint and help our customers achieve their sustainability goals.”

For direct emissions from its own operations and vehicle fleet, as well as indirect emissions from purchased energy - Scopes 1 and 2 -, Sartorius aims to reduce CO₂ equivalents in metric tons by 42 percent by 2030 compared with the base year 2022. The target now covers all relevant emission sources and exceeds the 95 percent coverage required by the Science Based Targets initiative. According to SBTi criteria, it is therefore aligned with the United Nations’ 1.5-degree Celsius target. The most important lever for reducing Scope 1 and 2 emissions at Sartorius remains the global transition of sites to renewable energy. An increasing number of facilities are to source electricity from renewable sources and heat, cooling, and steam is also planned to be generated sustainably.

For indirect emissions along the company’s value chain, the Sartorius Executive Board has defined an intensity target, assuming continued business growth: The company plans to reduce its Scope 3 emissions by 51.6 percent by 2030 compared to 2022 relative to the company’s value added1. The most important drivers are the decarbonization of the supply chain together with customers and suppliers, the eco-design of products and packaging, logistics, and sustainable building construction.

The company’s long-term climate ambition remains unchanged: Sartorius aims to have a climate-neutral value chain by 2045 and achieve net-zero greenhouse gas emissions by eliminating all avoidable emissions and offsetting the remaining ones.

The updated climate targets remain part of the long-term remuneration components of the Executive Board and replace the previous ones.


Learn more: www.sartorius.com/sustainability


A profile of Sartorius
Sartorius is a leading international partner to the biopharmaceutical research and manufacturing industries. The Lab Products & Services Division focuses on innovative laboratory instruments and consumables for research and quality assurance laboratories in pharmaceutical and biopharmaceutical companies as well as academic research institutions. The Bioprocess Solutions Division supports customers with a broad product portfolio focused on single-use solutions for the safer, faster, and more sustainable production of biotech drugs, vaccines, and cell and gene therapies. With around 60 production and sales locations worldwide, the Göttingen-based company has a strong global presence. Sartorius regularly supplements its portfolio with acquisitions of complementary technologies. In 2025, the company generated sales revenue of around 3.5 billion euros. More than 14,000 employees serve customers around the globe.

Visit our newsroom and follow us on LinkedIn.


Contact
Leona Malorny
Head of External Communications
+49 551 308 4067
leona.malorny@sartorius.com

Additional features:

File: 20260216_SAG_Media Release_Sartorius sharpens climate targets_en
File: Photo_Sartorius Campus in Göttingen


16.02.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: SARTORIUS AG
Otto-Brenner-Straße 20
37079 Göttingen
Germany
Phone: +49.(0)551-308.0
Fax: +49.(0)551-308.3289
E-mail: info@sartorius.com
Internet: www.sartorius.com
ISIN: DE0007165631, DE0007165607
WKN: 716563, 716560
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX
EQS News ID: 2276308

 
End of News EQS News Service

2276308  16.02.2026 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2020 2021 2022 2023 2024 2025e 2026e
Sales1 2.335,66 3.449,22 4.174,70 3.395,70 3.380,70 3.538,10 3.805,00
EBITDA1,2 636,70 1.134,26 1.410,40 962,70 945,30 1.051,60 1.165,00
EBITDA-Margin3 27,26 32,89 33,78 28,35 27,96 29,72 30,62
EBIT1,4 456,11 903,16 1.064,80 503,90 530,00 542,60 565,00
EBIT-Margin5 19,53 26,18 25,51 14,84 15,68 15,34 14,85
Net Profit (Loss)1 299,56 426,98 913,10 290,60 137,40 230,40 250,00
Net-Margin6 12,83 12,38 21,87 8,56 4,06 6,51 6,57
Cashflow1,7 511,53 865,81 734,20 853,60 976,00 837,00 860,00
Earnings per share8 4,38 8,09 9,58 4,95 5,30 4,79 5,30
Dividend per share8 0,71 1,26 1,44 0,74 0,74 0,74 1,44
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: PricewaterhouseCoopers

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Sartorius VZ
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
716563 DE0007165631 AG 15.095,81 Mio € 10.07.1990 Halten 9F3FHV2Q+JW
* * *
PE 2027e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
37,60 40,40 0,93 51,87 6,36 20,18 4,27
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,74 0,74 0,74 0,34%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
26.03.2026 23.04.2026 23.07.2026 22.10.2026 16.02.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-2,35%
220,30 €
ATH 631,60 €
-6,12% +1,67% -10,88% -10,01% +3.656,18%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2026          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 by Gereon Kruse #BGFL